KRAS and carcinoma: In addition, PI4KA tethering to the PM by EFR3 was found to increase the levels of KRAS, the most common human oncogene at the PM and its downstream signaling, thus providing a novel intervention route in KRAS-dependent carcinomas such as pancreatic, colorectal, or lung carcinoma [97].